Japanese pharmaceutical company Shionogi is planning a wide-ranging digital project that will see it ramp up its investment in cloud, cybersecurity and other technologies.

The work, which will also include a talent development programme, will be delivered by Accenture over seven years, with the consultants assisting with the firm’s IT strategy and roadmap.

Takuko Sawada, director and senior executive officer of Shionogi & Co, said: “As a drug discovery-based pharmaceutical company, our goal is to contribute to a more vigorous society through improved healthcare.

“To ensure sustainable growth and enhance our specialised business operations, we established six subsidiaries, including Shionogi Digital Science in April 2017. Through our initiatives with Accenture, we will streamline business operations by leveraging [cloud, cybersecurity etc], which will enhance our ability to leverage data analytics, enabling us to respond quickly to the rapidly evolving business landscape and promote innovative new drugs.”

The consultants will also help Shionogi enhance its IT division’s digital talent and capabilities through a knowledge-transfer program and accelerate the digitalisation of its business.

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more